The Lancet. NeurologyHumansAspirinMaleFemaleRetinal Artery Occlusion
Intravenous alteplase versus oral aspirin for acute central retinal artery occlusion within 4·5 h of severe vision loss (THEIA): a multicentre, double-dummy, patient-blinded and assessor-blinded, randomised, controlled, phase 3 trial.
Cécile Préterre, Aurélie Gaultier, Michael Obadia, Catherine Vignal, Isabelle Mourand, Julien Plat, Denis Sablot, Marie Gaudron, Gilles Rodier, Gaëlle Godeneche, Cédric Urbanczyk, Guillaume Marc, Evelyne Massardier, Sarah Adam, Marion Boulanger
Published: 202510.1016/S1474-4422(25)00308-4
Abstract
BACKGROUND: Central retinal artery occlusion (CRAO) is a subtype of ischaemic stroke that results in acute monocular vision loss. Although open-label studies and meta-analyses have suggested that early intravenous thrombolysis might improve visual ac…
Preview only. Read the full abstract at the source